Gene rearrangement study for minimal residual disease monitoring in children with acute lymphocytic leukemia

Assumpcao, Juliana Godoy; Paula, Francisco Danilo Ferreira; Xavier, Sandra Guerra; Murao, Mitiko; Aguirre Neto, Joaquim Caetano de; Dutra, Alvaro Pimenta; Lima, Eduardo Ribeiro; Oliveira, Benigna Maria de; Viana, Marcos Borato.
Rev. bras. hematol. hemoter ; 35(5): 337-342, 2013. tab, graf
Artigo em Inglês | LILACS | ID: lil-694084

Documentos relacionados

  1. Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.
  2. Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
  3. NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol.
  4. BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
  5. [Clinical analysis of newly diagnosed acute lymphoblastic leukemia with 11q23/MLL gene rearrangement].
  6. Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia.
  7. [Treatment strategy for infant acute lymphoblastic leukemia].
  8. Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.
  9. Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
  10. [Clinical Features and Prognosis of Acute Lymphoblastic Leukemia Children with P2RY8-CRLF2 Gene Rearrangement].